However, the tumor inhibition effect elicited by Gal1 knockdown was nullified when CD8+ T cells were depleted using an anti‐CD8 monoclonal antibody, indicating that Gal1 primarily acts by suppressing CD8+ T cells (Figure 2I,J). Here, CD8A is linked to neoplasm.